Sex differences in the risk of vascular and non-vascular complications in type 2 diabetes: the Fukuoka Diabetes Registry [0.03%]
2型糖尿病患者血管和非血管并发症风险的性别差异：福冈糖尿病注册中心数据研究
Toshiaki Ohkuma,Masanori Iwase,Taiki Higashi et al.
Toshiaki Ohkuma et al.
Aims: There is recent evidence for sex-based differences in complications associated with type 2 diabetes, with women showing a lower risk of macrovascular complications than men. However, sex differences in the risks of ...
Associations of age at T2D detection with hemoglobin A1c in a national inception cohort of U.S. Veterans with diabetes [0.03%]
美国退伍军人糖尿病国家初始队列中T2D检测年龄与血红蛋白A1c的关系
Sanja Avramovic,Xumin Li,Daniel A Enquobahrie et al.
Sanja Avramovic et al.
Objective: To investigate associations of age at type 2 diabetes (T2D) detection with HbA1c. Research design and methods: We examined a...
The association of weight status with glycemic control, diabetes related complications and anti-hyperglycemic medication use in patients with type 2 diabetes mellitus: The results of the Australian National Diabetes Audit (ANDA) 2015-2022 [0.03%]
体重状态与2型糖尿病患者血糖控制、糖尿病相关并发症和降糖药物使用之间的关系：澳大利亚国家糖尿病审计（ANDA）2015-2022年结果报告
N Szwarcbard,A Xiang,D Gasevic et al.
N Szwarcbard et al.
Aims: Type 2 diabetes has reached pandemic proportions; and obesity is considered one of its main drivers. We investigated the association of weight status with glycemic control, diabetes related complications and anti-hy...
Trends of lower-limb complications in patients with type 2 diabetes mellitus during the COVID-19 pandemic [0.03%]
新冠肺炎疫情期间2型糖尿病下肢并发症的变化趋势分析
Ivan Y Luu,Alexander T Hong,Forest Lin et al.
Ivan Y Luu et al.
Aims: The long-term impact of the COVID-19 pandemic on lower limb complications remains unclear. We aimed to assess the effect of the COVID-19 pandemic on the prevalence of diabetic foot ulcers (DFUs) and the incidence of...
Screening, prevalence, and burden of chronic kidney disease in people with type 2 diabetes managed by endocrinologists: A nationwide cross-sectional study [0.03%]
内分泌科管理的2型糖尿病人群的慢性肾脏病筛查、患病率和疾病负担：一项全国横断面研究
José Ignacio Martínez-Montoro,Jose Juan Aparicio-Sánchez,Belén Pimentel et al.
José Ignacio Martínez-Montoro et al.
Aims: To describe and characterize chronic kidney disease (CKD) prevalence, screening practices and associated burden on people with type 2 diabetes (T2D) managed by endocrinologists. ...
Comparative outcomes of adding SGLT2 inhibitors versus incretin-based therapies to insulin in type 2 diabetes [0.03%]
在胰岛素治疗的基础上加用钠-葡萄糖共转运体2抑制剂与肠促胰素类药物治疗2型糖尿病的比较结局
Fu-Shun Yen,James Cheng-Chung Wei,Yu-Han Huang et al.
Fu-Shun Yen et al.
Aims: To compare the risks of cardiovascular events and major microvascular complications associated with adding sodium-glucose cotransporter-2 (SGLT2) inhibitors versus dipeptidyl peptidase-4 (DPP-4) inhibitors or glucag...
GLP-1 receptor agonists and hospitalization due to infections in patients with type 2 diabetes: A nationwide cohort study [0.03%]
胰高糖素样肽-1受体激动剂与2型糖尿病患者因感染住院的关系：一项全国队列研究
Jiun-Ling Wang,Ching-Chi Lee,Wen-Chien Ko et al.
Jiun-Ling Wang et al.
Aims: Glucagon-like peptide 1 receptor agonists (GLP-1RAs) demonstrate pleiotropic effects, notably encompassing anti-inflammatory properties. We aim to compare the association of GLP-1RAs versus dipeptidyl peptidase-4 in...
Comparison of the prognostic value of different arterial sites atherosclerosis risk markers for development of Macro- and microvascular complications in individuals with type 2 diabetes: The Rio de Janeiro type 2 diabetes cohort study [0.03%]
不同类型动脉粥样硬化风险标志物预测糖代谢异常个体大、微血管并发症发生价值的队列研究：里约热内卢2型糖尿病人群队列研究结果
Claudia R L Cardoso,Nathalie C Leite,Alan C de Souza et al.
Claudia R L Cardoso et al.
Aims: Aortic stiffness, ankle-brachial index (ABI), and ultrasonographic carotid atherosclerosis (intima-media thickness and plaques) are preclinical atherosclerosis risk markers. However, their prognostic importance for ...
Biphasic effects of SGLT-2 inhibitors on sleep quality in older people with type 2 diabetes: A longitudinal analysis [0.03%]
SGLT-2抑制剂对老年2型糖尿病患者睡眠质量的双相影响：一项纵向分析
Betül Gülsüm Yavuz Veizi,Sultan Keskin Demircan
Betül Gülsüm Yavuz Veizi
Objective: Sodium-glucose cotransporter-2 (SGLT-2) inhibitors are widely used in type 2 diabetes mellitus (T2DM) due to their cardiometabolic benefits. However, their effects on sleep quality remain unclear. This study ex...
Efficacy and safety of SGLT-2 inhibitors in patients with comorbid type 2 diabetes and atrial fibrillation: A meta-analysis [0.03%]
钠-葡萄糖协同转运蛋白2抑制剂联合治疗伴房颤的2型糖尿病患者的疗效和安全性：一项系统综述和meta分析
Tang Tang,Mu Guo,Huimin Yu et al.
Tang Tang et al.
This meta-analysis investigated the efficacy and safety of sodium-glucose cotransporter-2 inhibitors (SGLT-2i) in patients with type 2 diabetes mellitus (T2DM) and atrial fibrillation (AF), a topic with limited prior consensus. A systematic...